Hetero Of India Gets Major Government Order For Tamiflu Generic
This article was originally published in PharmAsia News
Executive Summary
Indian drug maker Hetero Drugs has been asked by India's government to supply 10 million doses of a generic version of Roche's Tamiflu (oseltamivir) to treat the H1N1 virus. Hetero received the contract because it has the license from Roche to produce a generic in India. The firm outbid Cipla, Natco, Ranbaxy and Roche India to supply the drug to the government. Hetero said it would supply two million doses within days and another five million by the end of May, with the entire order to be completed by mid-June. (Click here for more